Physician profile
Mark Shearer
NPI 1376950113
$4,984.71
in general payments reported to CMS, 2019-2025
11 companies · $201 in 2025
The $201 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $908 · 2020: $817 · 2021: $376 · 2022: $1,476 · 2023: $1,122 · 2024: $84.04 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $698 · Travel and Lodging: $607 · Education: $102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $697.94 |
| Travel and Lodging | $606.89 |
| Education | $101.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,677.46 | 2021-2023 | Ortholoc 2 Lapifuse, Citrefix, Gravity Synchfix |
| Paragon 28, INC. | $1,316.79 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $821.50 | 2019-2024 | Incore Lapidus, Ceramentbone Void Filler, Stratum Foot Plating System |
| Smith+Nephew, INC. | $405.75 | 2019-2021 | |
| Treace Medical Concepts, INC. | $351.51 | 2022-2025 | |
| Organogenesis INC. | $172.69 | 2021-2023 | Puraply |
| Kci USA, INC. | $104.59 | 2019 | |
| Abbott Laboratories | $64.98 | 2019-2025 | Proclaim |
| Alaska Medical Technologies, LLC | $40.00 | 2025 | |
| Nevro Corp. | $16.70 | 2022 | |
| Bioventus LLC | $12.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Shearer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.